• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺病毒介导的PTEN转基因表达使表达Bcl-2的前列腺癌细胞对辐射敏感。

Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation.

作者信息

Rosser Charles J, Tanaka Motoyoshi, Pisters Louis L, Tanaka Noriyoshi, Levy Lawrence B, Hoover David C, Grossman H Barton, McDonnell Timothy J, Kuban Deborah A, Meyn Raymond E

机构信息

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

出版信息

Cancer Gene Ther. 2004 Apr;11(4):273-9. doi: 10.1038/sj.cgt.7700673.

DOI:10.1038/sj.cgt.7700673
PMID:14765130
Abstract

Bcl-2 is associated with resistance to radiotherapy in prostate cancer. It was recently demonstrated that transduction of LNCaP prostate cells with the PTEN gene resulted in Bcl-2 downregulation. We hypothesized that forced expression of PTEN in prostate cancer cells would sensitize cells to radiation, downregulate Bcl-2 expression, and potentiate the G2M block induced by radiation. Four cell lines - PC-3-Bcl-2 (Bcl-2 overexpression, deleted PTEN), PC-3-Neo (wild-type Bcl-2, deleted PTEN), LNCaP (Bcl-2 overexpression, deleted PTEN), and DU-145 (wild-type Bcl-2 and PTEN) - were transduced with a recombinant adenovirus-5 vector expressing the human wild-type PTEN cDNA under the control of a human cytomegalovirus promoter (Ad-MMAC). After correction for the effect of Ad-MMAC on plating efficiency, Ad-MMAC treatment reduced the surviving fractions after 2 Gy as follows: PC-3-Bcl-2, from 60.5 to 3.6%; PC-3-Neo, no reduction; LNCaP, from 29.6 to 16.3%; and DU-145, from 32.7 to 25.7%. PTEN expression was associated with the downregulation of Bcl-2 expression in PC-3-Bcl-2 and LNCaP cell lines. Ad-MMAC plus radiotherapy potentiated the G2M block seen with radiotherapy alone only in PC-3-Bcl-2 cells. These findings suggest that overexpression of Bcl-2 result in radioresistance and inability of radiation to cause its typical G2M cell-cycle arrest.

摘要

Bcl-2与前列腺癌放疗抵抗相关。最近有研究表明,用PTEN基因转导LNCaP前列腺细胞可导致Bcl-2表达下调。我们推测,在前列腺癌细胞中强制表达PTEN会使细胞对辐射敏感,下调Bcl-2表达,并增强辐射诱导的G2M期阻滞。用一种在人巨细胞病毒启动子(Ad-MMAC)控制下表达人野生型PTEN cDNA的重组腺病毒-5载体转导了四种细胞系——PC-3-Bcl-2(Bcl-2过表达,PTEN缺失)、PC-3-Neo(野生型Bcl-2,PTEN缺失)、LNCaP(Bcl-2过表达,PTEN缺失)和DU-145(野生型Bcl-2和PTEN)。在校正Ad-MMAC对铺板效率的影响后,Ad-MMAC处理使2 Gy照射后的存活分数降低如下:PC-3-Bcl-2,从60.5%降至3.6%;PC-3-Neo,无降低;LNCaP,从29.6%降至16.3%;DU-145,从32.7%降至25.7%。在PC-3-Bcl-2和LNCaP细胞系中,PTEN表达与Bcl-2表达下调相关。仅在PC-3-Bcl-2细胞中,Ad-MMAC联合放疗增强了单独放疗时出现的G2M期阻滞。这些发现表明,Bcl-2过表达导致放疗抵抗以及辐射无法引起其典型的G2M细胞周期阻滞。

相似文献

1
Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation.腺病毒介导的PTEN转基因表达使表达Bcl-2的前列腺癌细胞对辐射敏感。
Cancer Gene Ther. 2004 Apr;11(4):273-9. doi: 10.1038/sj.cgt.7700673.
2
PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancer.PTEN基因疗法可诱导前列腺癌生长受抑制,并提高化疗疗效。
Cancer Detect Prev. 2005;29(2):170-4. doi: 10.1016/j.cdp.2004.07.006. Epub 2004 Dec 10.
3
In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin.利用PTEN对人膀胱癌进行体内基因治疗可抑制肿瘤生长,下调磷酸化Akt,并增加对多柔比星的敏感性。
Gene Ther. 2003 Sep;10(19):1636-42. doi: 10.1038/sj.gt.3302056.
4
Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.腺病毒介导的MMAC/PTEN表达抑制人前列腺癌细胞的增殖和转移。
Clin Cancer Res. 2002 Jun;8(6):1904-14.
5
Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.腺病毒介导的p53转基因表达使野生型和p53缺失的前列腺癌细胞在体外对辐射敏感。
Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1507-12. doi: 10.1016/s0360-3016(00)01409-7.
6
PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression.PTEN通过抑制Bcl-2表达诱导PTEN突变的前列腺癌细胞的化学敏感性。
J Biol Chem. 2001 Oct 19;276(42):38830-6. doi: 10.1074/jbc.M103632200. Epub 2001 Aug 8.
7
Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.腺病毒介导的PTEN基因转移在体外和体内均可抑制人结直肠癌的生长。
Gene Ther. 2003 Nov;10(23):1961-9. doi: 10.1038/sj.gt.3302100.
8
PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway.PTEN通过一条依赖FADD的途径使前列腺癌细胞对死亡受体介导的及药物诱导的细胞凋亡敏感。
Oncogene. 2002 Jan 10;21(2):319-27. doi: 10.1038/sj.onc.1205054.
9
Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN.MMAC/PTEN对前列腺癌细胞中Akt/PKB活性、细胞生长及凋亡的调控
Cancer Res. 1999 Jun 1;59(11):2551-6.
10
MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.MMAC/PTEN肿瘤抑制基因调控前列腺癌中血管内皮生长因子介导的血管生成。
Int J Oncol. 2002 Sep;21(3):469-75.

引用本文的文献

1
PTEN-mediated resistance in cancer: From foundation to future therapies.PTEN介导的癌症耐药性:从基础到未来疗法
Toxicol Rep. 2025 Mar 4;14:101987. doi: 10.1016/j.toxrep.2025.101987. eCollection 2025 Jun.
2
Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer.白藜芦醇作为癌症化学增敏剂和放射增敏剂的分子机制
Front Pharmacol. 2023 Nov 10;14:1287505. doi: 10.3389/fphar.2023.1287505. eCollection 2023.
3
The use of adenoviral vectors in gene therapy and vaccine approaches.腺病毒载体在基因治疗和疫苗方法中的应用。
Genet Mol Biol. 2022 Oct 7;45(3 Suppl 1):e20220079. doi: 10.1590/1678-4685-GMB-2022-0079. eCollection 2022.
4
Potential Role of Natural Products to Combat Radiotherapy and Their Future Perspectives.天然产物在对抗放疗中的潜在作用及其未来展望。
Molecules. 2021 Oct 2;26(19):5997. doi: 10.3390/molecules26195997.
5
MicroRNA-221/222 Inhibits the Radiation-Induced Invasiveness and Promotes the Radiosensitivity of Malignant Meningioma Cells.微小RNA-221/222抑制辐射诱导的侵袭性并增强恶性脑膜瘤细胞的放射敏感性。
Front Oncol. 2020 Aug 25;10:1441. doi: 10.3389/fonc.2020.01441. eCollection 2020.
6
Nutraceutical Compounds as Sensitizers for Cancer Treatment in Radiation Therapy.营养药物化合物作为放射治疗中癌症治疗的增敏剂。
Int J Mol Sci. 2019 Oct 23;20(21):5267. doi: 10.3390/ijms20215267.
7
Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?联合聚(ADP-核糖)聚合酶抑制剂与放射疗法治疗胶质母细胞瘤:磷酸酶和张力蛋白同源物是否可预测疗效?
Clin Transl Oncol. 2017 Mar;19(3):273-278. doi: 10.1007/s12094-016-1547-4. Epub 2016 Sep 21.
8
Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers.靶向AKT信号通路:将HIV蛋白酶抑制剂重新定位为放射增敏剂。
Indian J Med Res. 2016 Feb;143(2):145-59. doi: 10.4103/0971-5916.180201.
9
Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.晚期直肠癌放疗前及放疗期间口服奈非那韦的临床试验
Clin Cancer Res. 2016 Apr 15;22(8):1922-31. doi: 10.1158/1078-0432.CCR-15-1489. Epub 2016 Feb 9.
10
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment.复发性前列腺癌基因组改变可预测对近距离放射治疗的反应。
Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):594-600. doi: 10.1158/1055-9965.EPI-13-1180. Epub 2014 Feb 10.